Research Article

Revisiting Cancer Diagnosis in Scotland: Further Insights from the Second Scottish National Cancer Diagnosis Audit

Table 4

Primary care interval (PCI) descriptive statistics with percentages of patients with PCI of >60 and >90 days for 2019 (excluding screening detected patients1).

TotalMissingPrimary care intervalPCI >60 daysPCI >90 days
NNMedian days (25th–75th centile)%%

Total21256024 (0–22)10.97.5
Sex
 Male10923317 (0–28)11.37.4
 Female10332712 (0–17)10.57.6
Age categories (years)
 0–242676 (0–15)00
 25–49197391 (0–16)127
 50–645191193 (0–19.5)10.37.3
 65–746421726 (0–27)11.78.3
 75–845511893 (0–21)9.46.4
 ≥85190767 (0–33)14.910.5
Cancer site categories
 Bladder59166 (0–21)16.39.3
 Brain37164 (1–25)n < 5n < 5
 Breast211240 (0-1)5.34.3
 Colon170477 (1–21)14.611.4
 Gynae–others88111 (0–4)n < 5n < 5
 Leukaemia45203 (1–22)1212
 Liver and bile tract54237 (0–32)12.99.7
 Lung and bronchus3711448 (0–29)9.35.3
 Lymphoma101269 (0–42)14.710.7
 Melanoma117210 (0–2)7.36.3
 Multiple myeloma301627 (3–49)n < 5n < 5
 Oesophageal62103 (0–27.5)11.5n < 5
 Oral/oropharyngeal72294 (0–57)23.314
 Others108337 (0–33)9.35.3
 Ovarian45116 (0–29)11.8n < 5
 Pancreas50132 (0–22)n < 5n < 5
 Prostate2887411 (3–28)12.68.9
 Rectal69123 (0–26)19.312.3
 Renal71243 (0–24)8.5n < 5
 Stomach and small intestine68268.5 (1–29)14.311.9
 Unknown primary9655 (14–76)n < 50
Comorbidity category
 None5261053 (0–20)10.27.8
 16251684 (0–22)11.66.8
 24701393 (0–21)106.6
 ≥34811796 (0–29)11.98.9
Patient SIMD at diagnosis
 14171443 (0–23)8.84
 24041164 (0–20)95.9
 34151163 (0–28)149.7
 43921063.5 (0–21)11.28.7
 54821144 (0–24)11.48.7
2-fold urban rural classification
 Urban16554833 (0–20)10.26.7
 Rural4491107 (0–29)13.910.3

1The 2019 survey included an initial question: “Was the patient’s cancer known to be detected by NHS cancer screening services relevant to this diagnosis?” any patient where the GP had responded yes to this question were excluded from further analysis and accounts for the difference in valid N between the analysis on referrals compared with PCI/DI.